CD276 and neoplasm: Finally, to mimic trogocytosis in vivo, we treated an animal model of high tumor burden with EGFRvIII-targeted (against U87 EGFRvIII high density) or B7-H3-targeted CAR-T (against GSCs) and harvested the tumor tissue two days post-infusion (Supplementary Fig. 6a).